Calcification of primary human osteoblast cultures under flow conditions using polycaprolactone scaffolds for intravascular applications

Journal of Tissue Engineering and Regenerative Medicine

Volumn 6, Issue 9, 2012, Pages 687-695

  Zhu, Beili ^a   Bailey, Steven R ^a,b   Mauli Agrawal, C ^a  

^a University of Texas at San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Calcification; Dynamic flow; PCL; Polycaprolactone; Primary human osteoblast; Scaffold; Tissue engineering; Total atherosclerotic occlusion

Indexed keywords

ANIMALS; BIOMINERALIZATION; CALCIFICATION (BIOCHEMISTRY); CALCIUM; CELLS; CYTOLOGY; POLYCAPROLACTONE; SCAFFOLDS (BIOLOGY);

CELL NUMBER; DYNAMIC FLOWS; FLOW CONDITION; HUMAN OSTEOBLAST; OSTEOBLAST CULTURES; POLYCAPROLACTONE SCAFFOLDS; PRIMARY HUMAN OSTEOBLASTS; TGF-Β1; TISSUES ENGINEERINGS; TOTAL ATHEROSCLEROTIC OCCLUSION;

BONE;

ALKALINE PHOSPHATASE; POLYCAPROLACTONE; TISSUE SCAFFOLD; TRANSFORMING GROWTH FACTOR BETA; BIOCOMPATIBLE COATED MATERIAL; CALCIUM; POLYESTER; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTICLE; CALCIFICATION; CELL COUNT; CONTROLLED STUDY; DEGRADATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; NONHUMAN; OSTEOBLAST; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; TISSUE ENGINEERING; ANIMAL; ATHEROSCLEROSIS; BIOLOGICAL MODEL; BIOREACTOR; CALCINOSIS; CELL CULTURE; CELL DIFFERENTIATION; CHEMISTRY; DRUG EFFECTS; FLOW KINETICS; MATERIALS TESTING; METABOLISM; PATHOLOGY; PROCEDURES; TISSUE SCAFFOLD;

ALKALINE PHOSPHATASE; ANIMALS; ATHEROSCLEROSIS; BIOREACTORS; CALCINOSIS; CALCIUM; CELL COUNT; CELL DIFFERENTIATION; CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; HUMANS; MATERIALS TESTING; MODELS, CARDIOVASCULAR; OSTEOBLASTS; POLYESTERS; RHEOLOGY; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84867098755     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.472     Document Type: Article

References (41)

1. Abedin M, Tintut Y, Demer LL. 2004; Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 24(7): 1161-1170.
2. Agrawal CM, McKinney JS, Lanctot D, et al. 2000; Effects of fluid flow on the in vitro degradation kinetics of biodegradable scaffolds for tissue engineering. Biomaterials 21(23): 2443-2452.
3. Alexopoulos N, Raggi P. 2009; Calcification in atherosclerosis. Nat Rev Cardiol 6(11): 681-688.
4. Barralet JE, Wallace LL, Strain AJ. 2003; Tissue engineering of human biliary epithelial cells on polyglycolic acid/polycaprolactone scaffolds maintains long-term phenotypic stability. Tissue Eng 9(5): 1037-1045.
5. Bilgen B, Barabino GA. 2007; Location of scaffolds in bioreactors modulates the hydrodynamic environment experienced by engineered tissues. Biotechnol Bioeng 98(1): 282-294.
6. Botchwey EA, Pollack SR, El-Amin S, et al. 2003; Human osteoblast-like cells in three-dimensional culture with fluid flow. Biorheology 40(1-3): 299-306.
7. Cabrera R, Sha Z, Vadakkan TJ, et al. 2010; Proteasome nuclear import mediated by Arc3 can influence efficient DNA damage repair and mitosis in Schizosaccharomyces pombe. Mol Biol Cell 21(18): 3125-3136.
8. Chen HC, Hu YC. 2006; Bioreactors for tissue engineering. Biotechnol Lett 28(18): 1415-1423.
9. Chim H, Ong JL, Schantz JT, et al. 2003; Efficacy of glow discharge gas plasma treatment as a surface modification process for three-dimensional poly(d, l-lactide) scaffolds. J Biomed Mater Res A 65(3): 327-335.
10. Daugherty A. 2002; Mouse models of atherosclerosis. Am J Med Sci 323(1): 3-10.
11. Facer SR, Zaharias RS, Andracki ME, et al. 2005; Rotary culture enhances pre-osteoblast aggregation and mineralization. J Dent Res 84(6): 542-547.
12. Fassina L, Visai L, Asti L, et al. 2005; Calcified matrix production by SAOS-2 cells inside a polyurethane porous scaffold, using a perfusion bioreactor. Tissue Eng 11(5-6): 685-700.
13. Freed LE, Guilak F, Guo XE, et al. 2006; Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling. Tissue Eng 12(12): 3285-3305.
14. Giachelli CM. 2004; Vascular calcification mechanisms. J Am Soc Nephrol 15(12): 2959-2964.
15. Giachelli CM. 2005; Inducers and inhibitors of biomineralization: lessons from pathological calcification. Orthod Craniofac Res 8(4): 229-231.
16. Grellier M, Bareille R, Bourget C, et al. 2009; Responsiveness of human bone marrow stromal cells to shear stress. J Tissue Eng Regen Med 3(4): 302-309.
17. Guarino V, Causa F, Taddei P, et al. 2008; Polylactic acid fibre-reinforced polycaprolactone scaffolds for bone tissue engineering. Biomaterials 29(27): 3662-3670.
18. Hsu JJ, Tintut Y, Demer LL. 2008; Murine models of atherosclerotic calcification. Curr Drug Targets 9(3): 224-228.
19. Kapur S, Baylink DJ, Lau KH. 2003; Fluid flow shear stress stimulates human osteoblast proliferation and differentiation through multiple interacting and competing signal transduction pathways. Bone 32(3): 241-251.
20. Liegibel UM, Sommer U, Bundschuh B, et al. 2004; Fluid shear of low magnitude increases growth and expression of TGFβ1 and adhesion molecules in human bone cells in vitro. Exp Clin Endocrinol Diabetes 112(7): 356-363.
21. Martin I, Wendt D, Heberer M. 2004; The role of bioreactors in tissue engineering. Trends Biotechnol 22(2): 80-86.
22. Narayanaswamy M, Wright KC, Kandarpa K. 2000; Animal models for atherosclerosis, restenosis, and endovascular graft research. J Vasc Interv Radiol 11(1): 5-17.
23. Petrie Aronin CE, Cooper JA Jr, Sefcik LS, et al. 2008; Osteogenic differentiation of dura mater stem cells cultured in vitro on three-dimensional porous scaffolds of poly(ε-caprolactone) fabricated via co-extrusion and gas foaming. Acta Biomater 4(5): 1187-1197.
24. Prosser L, Agrawal CM, Polan J, et al. 2006; Implantation of oxygen enhanced, three-dimensional microporous l-PLA polymers: a reproducible porcine model of chronic total coronary occlusion. Catheter Cardiovasc Interv 67(3): 412-416.
25. Radke PW, Heinl-Green A, Frass OM, et al. 2006; Evaluation of the porcine ameroid constrictor model of myocardial ischemia for therapeutic angiogenesis studies. Endothelium 13(1): 25-33.
26. Schwartz Z, Denison TA, Bannister SR, et al. 2007; Osteoblast response to fluid induced shear depends on substrate microarchitecture and varies with time. J Biomed Mater Res A 83(1): 20-32.
27. Segev A, Nili N, Qiang B, et al. 2005; Human-grade purified collagenase for the treatment of experimental arterial chronic total occlusion. Cardiovasc Revasc Med 6(2): 65-69.
28. Sha Z, Yen HC, Scheel H, et al. 2007; Isolation of the Schizosaccharomyces pombe proteasome subunit Rpn7 and a structure-function study of the proteasome-COP9-initiation factor domain. J Biol Chem 282(44): 32414-32423.
29. Sha Z, Brill LM, Cabrera R, et al. 2009; The eIF3 interactome reveals the translasome, a supercomplex linking protein synthesis and degradation machineries. Mol Cell 36(1): 141-152.
30. Shioi A, Mori K, Jono S, et al. 2000; Mechanism of atherosclerotic calcification. Z Kardiol 89(suppl 2): 75-79.
31. Sikavitsas VI, Bancroft GN, Mikos AG. 2002; Formation of three-dimensional cell/polymer constructs for bone tissue engineering in a spinner flask and a rotating wall vessel bioreactor. J Biomed Mater Res 62(1): 136-148.
32. Sinha S, Eddington H, Kalra PA. 2009; Vascular calcification: lessons from scientific models. J Ren Care 35(suppl 1): 51-56.
33. Sucosky P, Osorio DF, Brown JB, et al. 2004; Fluid mechanics of a spinner-flask bioreactor. Biotechnol Bioeng 85(1): 34-46.
34. Suzuki K, Saito N, Zhang G, et al. 2008; Development of a novel calcified total occlusion model in porcine coronary arteries. J Invasive Cardiol 20(6): 296-301.
35. Suzuki Y, Oyane A, Ikeno F, et al. 2009; Development of animal model for calcified chronic total occlusion. Catheter Cardiovasc Interv 74(3): 468-475.
36. Trion A, van der Laarse A. 2004; Vascular smooth muscle cells and calcification in atherosclerosis. Am Heart J 147(5): 808-814.
37. Vattikuti R, Towler DA. 2004; Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 286(5): E686-E696.
38. Wang TW, Wu HC, Wang HY, et al. 2009; Regulation of adult human mesenchymal stem cells into osteogenic and chondrogenic lineages by different bioreactor systems. J Biomed Mater Res A 88(4): 935-946.
39. Yanni AE. 2004; The laboratory rabbit: an animal model of atherosclerosis research. Lab Anim 38(3): 246-256.
40. Zhao F, Chella R, Ma T. 2007; Effects of shear stress on 3D human mesenchymal stem cell construct development in a perfusion bioreactor system: experiments and hydrodynamic modeling. Biotechnol Bioeng 96(3): 584-595.
41. Zhu B, Bailey SR, Mauli Agrawal C. 2011; Engineering calcium deposits on polycaprolactone scaffolds for intravascular applications using primary human osteoblasts. J Tissue Eng Regen Med 5(4): 324-336.